Facebook
X
LinkedIn
Forward2025 Imagine - W26 - Maximizing Financial Success in Healthcare - On Demand
The healthcare landscape faces increasing financial pressures due to shifting reimbursement models, rising operational costs, regulatory changes and evolving patient expectations. This session will explore a strategic approach to innovative financial strategies that help optimize revenue, control expenses and enhance operational efficiency across care delivery organizations. Attendees will gain insights into revenue cycle management, specialty optimization, staffing models and supply chain improvements to drive financial success in today’s evolving healthcare environment.
Target Audience
- Dietitians
- Nurses
- Pharmacists
- Pharmacy Technicians
- Physicians
- Physician Associates
- Other Healthcare Professionals
Learning Objectives
Upon completing this enduring material, learners should be able to:
- Identify key revenue optimization strategies, including specialty expansion and payer contracting improvements.
- Discuss cost management techniques, including staffing efficiencies and supply chain optimization, to drive financial success.
Statement of Content Validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
Disclaimer
The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
Faculty & Planners
Faculty
Planning Committee
Juli Hermanson, MPH, RDN, CPHQ (Course Director)
Senior Director
Member Education
Vizient, Inc.
Kathy Christensen, BS
VP, Operations
Member Networks
Vizient, Inc.
Cheryl Jachna, BS
Lead Education Programs Manager
Vizient, Inc.
Marilu Kelly, MSN, RN, NPD-BC, CHCP
Director
Continuing Education
Vizient, Inc.
David Levine, MD
Chief Medical Officer
Vizient, Inc.
Lisa McClain, BS
Networks Manager
Member Education
Vizient, Inc.
Mike Oinonen, PharmD, MPH
Vice President
Pharmacy Networks
Vizient, Inc.
Disclosure
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Disclosure Statements
Absence of Relevant Financial Relationships
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships listed for these individual(s) have been mitigated.
Joint Accreditation Statement
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statement(s)
Interprofessional Continuing Education (IPCE)
This activity was planned by, and for, the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) credits for learning and change.
Registered Dietitians/Dietetic Technicians (CDR)
The Commission on Dietetic Registration (CDR) accepts nutrition-and-dietetics-related continuing education credits from Jointly Accredited Providers. After completing this activity, CDR-credentialed practitioners may claim CPEUS under Activity Type 102; 1 contact hour (60 minutes) = 1 CPEU.
Nurses (CNE)
This activity is designated for 0.75 ANCC contact hours.
Pharmacists (CPE)
Vizient, Inc. designates this enduring material for a maximum of 0.75 contact hours for Pharmacists.
Universal Activity Number: JA0006103-0000-25-268-H04-P
Pharmacy Technicians (CPE)
Vizient, Inc. designates this enduring material for a maximum of 0.75 contact hours for Pharmacy Technicians.
Universal Activity Number: JA0006103-0000-25-268-H04-T
Physicians (CME)
Vizient, Inc. designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associates (AAPA)
Vizient, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until October 6, 2026. PAs should only claim credit commensurate with the extent of their participation.
Other Healthcare Professionals (General CE Credit)
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.
Available Credit
- 0.75 AAPA CMEVizient Inc. has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.
- 0.75 ACPE Pharmacist
- 0.75 ACPE Pharmacy Technician
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
- 0.75 CDR
- 0.75 General CE - Attendance
Select the “Obtain Credit” button to access the session evaluation and to claim CE Credit.
Please Note:
- If the "Register/Take Course" tab is displayed instead of the "Obtain Credit" tab, you must first login to proceed with the credit claim process.
- This activity requires learners to confirm their attendance using an activity code. An Access Denied error message indicates that your attendance was not recorded via SMS text or QR code scanning.
- Please click here to enter the code you received at the end of the session to verify your attendance if you have not already done so: https://continuingeducation.vizientinc.com/code
Required Hardware/software
The Vizient CE Learner Portal is compatible with most modern web browsers (such as Firefox, Google Chrome, Microsoft Edge, Apple Safari) and can also be accessed with mobile devices.